Download IMpower110: atezolizumab vs chemo in PD-L1–selected NSCLC

IMpower110: atezolizumab vs chemo in PD-L1–selected NSCLC, Just Download and Share, Go Viral


Uploaded On 15 May 2024   ⚊   (9 hours ago)
Channel VJOncology
Size 4 MB
Duration 00:30
Share        

Direct Download

Click and Copy Audio Links

Click and Copy Video Links

Tags:
IMpower110AtezolizumabVsChemoPDL1selectedNSCLC
You May Also Like (Similar) IMpower110: atezolizumab vs chemo in PD-L1–selected NSCLC
HD Poster ESMO 2023 highlights: advances in EGFR+ lung cancer second-line therapy
ESMO 2023 highlights: advances in EGFR+ lung cancer second-line therapy
Duration: 1:00
HD Poster ADCs for lung cancer
ADCs for lung cancer
Duration: 1:49
HD Poster Phase Ib data CAPItello-292: capivasertib + palbociclib + fulvestrant in HR+/HER2- breast cancer
Phase Ib data CAPItello-292: capivasertib + palbociclib + fulvestrant in HR+/HER2- breast cancer
Duration: 1:49
HD Poster VJOncology at BTOG 2023
VJOncology at BTOG 2023
Duration: 0:34
HD Poster Combining radiotherapy with novel agents in NSCLC
Combining radiotherapy with novel agents in NSCLC
Duration: 0:47
HD Poster IMbrave050: adjuvant atezolizumab with bevacizumab in high-risk HCC
IMbrave050: adjuvant atezolizumab with bevacizumab in high-risk HCC
Duration: 3:42
HD Poster CAPItello-291: capivasertib +fulvestrant for AI-resistant HR+/HER2- advanced breast cancer
CAPItello-291: capivasertib +fulvestrant for AI-resistant HR+/HER2- advanced breast cancer
Duration: 5:28
HD Poster IMpower110: atezolizumab vs chemo in PD-L1–selected NSCLC
IMpower110: atezolizumab vs chemo in PD-L1–selected NSCLC
Duration: 4:18
HD Poster Active surveillance in localized prostate cancer
Active surveillance in localized prostate cancer
Duration: 4:12
HD Poster Updated overall efficacy and safety of selpercatinib in patients with RET fusion+ NSCLC
Updated overall efficacy and safety of selpercatinib in patients with RET fusion+ NSCLC
Duration: 2:52
HD Poster The use of photopheresis for the treatment of cutaneous T-cell lymphoma
The use of photopheresis for the treatment of cutaneous T-cell lymphoma
Duration: 3:22
HD Poster Ki-67 index after neoadjuvant ET as a prognostic biomarker for HR+/HER2- early breast cancer
Ki-67 index after neoadjuvant ET as a prognostic biomarker for HR+/HER2- early breast cancer
Duration: 6:09
HD Poster Updated analysis of DESTINY-Gastric02: T-DXd in HER2+ GEJ cancer who progressed with trastuzumab
Updated analysis of DESTINY-Gastric02: T-DXd in HER2+ GEJ cancer who progressed with trastuzumab
Duration: 2:58
HD Poster The role of PSMA PET in recurrent prostate cancer
The role of PSMA PET in recurrent prostate cancer
Duration: 3:50
HD Poster ALTERNATE: neoadjuvant endocrine treatment in ER+/HER2- breast cancer
ALTERNATE: neoadjuvant endocrine treatment in ER+/HER2- breast cancer
Duration: 3:44
HD Poster Tyrosine kinase inhibitors in EGFR-mutant NSCLC: when and who?
Tyrosine kinase inhibitors in EGFR-mutant NSCLC: when and who?
Duration: 4:09
HD Poster Unequal access to contralateral mastectomy for breast cancer patients in the UK
Unequal access to contralateral mastectomy for breast cancer patients in the UK
Duration: 1:03
HD Poster Novel treatment approaches in pancreatic cancer therapy
Novel treatment approaches in pancreatic cancer therapy
Duration: 0:56
HD Poster Clinical targeting of adaptive resistance in colorectal cancer
Clinical targeting of adaptive resistance in colorectal cancer
Duration: 0:40
Category's
Bhupen Hazarika
Zubeen Garg
Papon (Angarag Mahanta)
Jayanta Hazarika
Parineeta Borthakur
Dipali Borthakur
Anima Choudhury
Khagen Mahanta
Jitul Sonowal
Manas Robin
Bornali Kalita
Nekib
Joi Barua
Achurjya Borpatra
Priyanka Bharali
Simanta Shekhar
Anindita Paul
Rupam Bhuyan
Babu Baruah
Deeplina Deka
Pranjal Parash
Nilotpal Bora
Pompi Gogoi
Jitul Sonowal
Tarali Sharma
Surajeet Protim Saikia
Anindita Paul
Subasana Dutta
Ritrisha Sarmah
Zishan Zahir
Kusum Kailash
Rimjhim Priyanka Baruah
Kallol Borthakur
Dikshu
Jyotishma Sharma
Priyam Pallabee
Gitali Kakati
Bhitali Das